FDA to delay decision on Eli Lilly Alzheimer's drug for second time
Go back to FDA to delay decision on Eli Lilly Alzheimer's drug for second time| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 215.50 -3.55 (1.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.05 | 52 Week High | $333.65 | |||
| Open | $219.05 | 52 Week Low | $223.02 | |||
| Day High | $220.17 | P/E | 27.59 | |||
| Day Low | $215.26 | EPS | $7.81 | |||
| Volume | 2,635,886 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1152.93 +0.49 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.44 | 52 Week High | $88.16 | |||
| Open | $1150.00 | 52 Week Low | $67.88 | |||
| Day High | $1157.60 | P/E | 266.88 | |||
| Day Low | $1140.27 | EPS | $4.32 | |||
| Volume | 4,549,709 | |||||
